Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Shanghai Pharmaceuticals Holding Co., Ltd, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 6.64x |
| P/B Ratio | 0.50x |
| P/S Ratio | 0.13x |
| Profitability | |
| Gross Margin | 10.7% |
| Operating Margin | 3.5% |
| Net Margin | 2.0% |
| EBITDA Margin | 5.1% |
| Liquidity | |
| Current Ratio | 1.33x |
| Quick Ratio | 1.00x |
| Leverage | |
| Debt/Equity | 0.65x |
YoY = year-over-year change. Source: FMP..